2-(4--(methylamino)phenyl)-6-hydroxybenzothiazole and Meningioma

2-(4--(methylamino)phenyl)-6-hydroxybenzothiazole has been researched along with Meningioma* in 4 studies

Other Studies

4 other study(ies) available for 2-(4--(methylamino)phenyl)-6-hydroxybenzothiazole and Meningioma

ArticleYear
Pittsburgh Compound-B Uptake in Meningioma With Histopathologic Correlation.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:7

    Previous studies have reported increased Pittsburgh compound-B (PiB) uptake in meningiomas; however, histological correlation to elucidate the underlying mechanism has not yet been done. We report a case of an 82-year-old woman with an incidental intracranial tumor that showed focal increased PiB uptake. Because of tumor growth, surgical resection was performed, yielding a histological diagnosis of meningioma. Any special and immunochemical staining for amyloid did not reveal amyloid deposition in the tumor. Our findings suggest that increased PiB uptake was not associated with amyloid in this instance.

    Topics: Aged, 80 and over; Aniline Compounds; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles

2019
Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors.
    Journal of neuro-oncology, 2018, Volume: 136, Issue:2

    Meningiomas are the most common intracranial tumors. Diagnosis by MRI is generally straightforward, but lack of imaging specificity can present a diagnostic dilemma, particularly in patients with cancer. We report our experience with meningioma identification on Pittsburgh compound B (PiB) PET/CT. Patients who underwent PiB PET/CT from 2006 to 2015 were reviewed to identify those with intracranial tumors. Tumor types were classified by MR appearance, or by pathology when available. Maximum standardized uptake value (SUVmax) measurements of tumor PiB activity were compared across tumor types. 2472 patients underwent PiB PET/CT in the period of interest; 45 patients (1.8%) had probable or definite intracranial tumor. Tumor types were meningioma (29/45, 64%), vestibular schwannoma (7/45, 16%), pituitary macroadenoma (4/45, 9%), metastatic disease (2/45, 4%), and others (3/45, 7%). In patients with meningioma, the mean lesion SUVmax was 2.05 (SD 1.37), versus 1.00 (SD 0.42) in patients with non-meningioma tumors (pā€‰<ā€‰0.01). A receiver operating curve was created for lesion:cerebellum SUVmax ratio, with an area under the curve of 0.91 for a value of 1.68. At or above this ratio, specificity for meningioma was 100% (95% CI 79-100%) and sensitivity was 76% (95% CI 57-90%). PiB PET activity within an intracranial tumor is a highly specific and reasonably sensitive marker of meningioma. Further prospective evaluation is warranted to validate this result as well as to assess the performance of commercially available beta-amyloid radiotracers in meningioma identification.

    Topics: Aged; Aged, 80 and over; Aniline Compounds; Brain Neoplasms; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thiazoles

2018
Sphenoid wing meningioma behavior on 11C-PiB and 18F-FDG PET.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:1

    Two patients with mild cognitive impairment underwent C-PiB and F-FDG brain PET. Both patients had previously gone through a contrast-enhanced MRI scan that revealed extra-axial tumors next to the sphenoid wing, suggestive of meningiomas. C-PiB PET images showed a highly increased uptake by the extra-axial masses. These 2 cases represent 1.2% of our C-PiB population (n = 163). No meningioma was found with negative C-PiB uptake. The F-FDG concentration was not increased within the lesions. C-PiB could be used as a meningioma marker.

    Topics: Aged; Aniline Compounds; Benzothiazoles; Female; Fluorodeoxyglucose F18; Humans; Meningeal Neoplasms; Meningioma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles; Tomography, X-Ray Computed

2015
Incidental finding of meningioma on C11-PIB PET.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:2

    As a healthy volunteer for amyloid imaging study, a 83-year-old woman with no history of neurologic or psychiatric illness underwent carbon 11-labeled Pittsburgh compound-B (PIB) PET, which showed focal increased PIB binding in the right anterior temporal region. This focal PIB uptake turned out to be a mass lesion on MRI, which was consistent with a benign meningioma. This is the first case report on the incidentally found intracranial meningioma by PIB PET scan, highlighting the excellent sensitivity of PIB radiotracer in detecting brain amyloid deposition.

    Topics: Aged, 80 and over; Aniline Compounds; Carbon Radioisotopes; Female; Humans; Incidental Findings; Meningeal Neoplasms; Meningioma; Positron-Emission Tomography; Thiazoles

2012